domingo, 7 de octubre de 2012

National Guideline Clearinghouse | Diagnosis and management of acute graft-versus-host disease.

full-text ►
National Guideline Clearinghouse | Diagnosis and management of acute graft-versus-host disease.

Guideline Title

Diagnosis and management of acute graft-versus-host disease.

Bibliographic Source(s)

Dignan FL, Clark A, Amrolia P, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Hadzic N, Shaw BE, Potter MN, on behalf of the Haemato-oncology Task Force of the British Committee [trunc]. Diagnosis and management of acute graft-versus-host disease. Br J Haematol 2012 Jul;158(1):30-45. [137 references] PubMed External Web Site Policy

Guideline Status

This is the current release of the guideline.

Br J Haematol. 2012 Jul;158(1):30-45. doi: 10.1111/j.1365-2141.2012.09129.x. Epub 2012 Apr 26.

Diagnosis and management of acute graft-versus-host disease.

Dignan FL, Clark A, Amrolia P, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Hadzic N, Shaw BE, Potter MN; Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation.

Source

Section of Haemato-oncology, The Royal Marsden NHS Foundation Trust, London, UK.

Abstract

A joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Society for Bone Marrow Transplantation (BSBMT) has reviewed the available literature and made recommendations for the diagnosis and management of acute graft-versus-host disease. This guideline includes recommendations for the diagnosis and grading of acute graft-versus-host disease as well as primary treatment and options for patients with steroid-refractory disease. The goal of treatment should be effective control of graft-versus-host disease while minimizing risk of toxicity and relapse.
© 2012 Blackwell Publishing Ltd.